AVNS
Avanos Medical, Inc.
NYSE · Healthcare · Medical - Devices · US
$24.99
+0.04%Year over year
Reported trailing growth
- Revenue
- +3.9%
- EBITDA
- +93.7%
- EBIT
- —
- EPS
- +82.1%
- Free cash flow
- -93.4%
- Operating cash flow
- -72.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +0.8%
- EBITDA
- +90.4%
- EBIT
- —
- Net income
- +82.7%
- EPS
- +82.9%
- Free cash flow
- -15.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026